000 01000 a2200229 4500
005 20250516140748.0
008 ####s 0 0 eng d
022 _a2162-4011
024 7 _a10.4161/onci.23914
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFoy, Kevin C
245 0 0 _aCorrection to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060.
_h[electronic resource]
260 _bOncoimmunology
_c01 2013
300 _ae23914 p.
_bdigital
500 _aPublication Type: Journal Article; Published Erratum
700 1 _aMiller, Megan J
700 1 _aMoldovan, Nicanor
700 1 _aCarson, William E
700 1 _aKaumaya, Pravin P T
773 0 _tOncoimmunology
_gvol. 2
_gno. 1
_gp. e23914
856 4 0 _uhttps://doi.org/10.4161/onci.23914
_zAvailable from publisher's website
999 _c22571342
_d22571342